Pharmaron Total Assets from 2010 to 2024

300759 Stock   26.95  0.23  0.86%   
Pharmaron Beijing's Total Assets are increasing over the years with slightly volatile fluctuation. Total Assets are expected to dwindle to about 13.6 B. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2019-03-31
Previous Quarter
25.2 B
Current Value
23 B
Quarterly Volatility
6.6 B
 
Covid
Check Pharmaron Beijing financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaron Beijing's main balance sheet or income statement drivers, such as Tax Provision of 176.8 M, Interest Income of 30.2 M or Interest Expense of 191.3 M, as well as many indicators such as . Pharmaron financial statements analysis is a perfect complement when working with Pharmaron Beijing Valuation or Volatility modules.
  
This module can also supplement various Pharmaron Beijing Technical models . Check out the analysis of Pharmaron Beijing Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Pharmaron Stock

Pharmaron Beijing financial ratios help investors to determine whether Pharmaron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaron with respect to the benefits of owning Pharmaron Beijing security.